CN Patent

CN102149717A — 二氧杂-双环[3.2.1]辛烷-2,3,4-三醇衍生物

Assigned to Pfizer Inc · Expires 2011-08-10 · 15y expired

What this patent protects

本文描述了式(I)化合物，及其用于治疗由钠-葡萄糖转运蛋白抑制剂(特别是SGLT2抑制剂)介导的疾病、症状及/或病症治疗的用途。

USPTO Abstract

本文描述了式(I)化合物，及其用于治疗由钠-葡萄糖转运蛋白抑制剂(特别是SGLT2抑制剂)介导的疾病、症状及/或病症治疗的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN102149717A
Jurisdiction
CN
Classification
—
Expires
2011-08-10
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.